European Thoracic Oncology Platform


14.10.2014 | Advanced Disease
[Articles] Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
14.10.2014 | Advanced Disease
[Articles] Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data
14.10.2014 | Locally Advanced Disease
Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors
14.10.2014 | Locally Advanced Disease
Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT
14.10.2014 | Early Disease
Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.


17.10.2014 | ETOP News
esmo-2014The ETOP Slide deck from ESMO 2014, realised with support by Eli Lilly, is now available. Please register for free to gain access.
25.09.2014 | ETOP News
etopdata-shortlisted-for-research-biobank-of-the-year-competition-rbycThe ETOPdata iBiobank and Trial Platform is shortlisted for the Research Biobank of the Year Competition (RBYC) which takes place during the ESBB (in Leipzig, Germany Oct. 21st to 24th, 2014.
30.06.2014 | ETOP News
elcc-2015-save-the-dateSave the date for the 5th European Lung Cancer Conference, organised by IASLC and ESMO, 15-18 April in Geneva, Switzerland.  
16.06.2014 | ETOP News
etop-slide-deck-from-2014-asco-annual-meetingThe ETOP Slide deck from the 2014 ASCO Annual Meeting, realised with support by Eli Lilly, is now available. Please register for free to gain access.  
04.06.2014 | ETOP News
etop-meeting-2014-in-viennaThe next ETOP Meeting will take place Nov 14/15 2014 in Vienna. More information can be found here.    

Lung Cancer Journal

ETOP members have free access to the Lung Cancer Journal